Armistice Capital, Llc Avalo Therapeutics, Inc. (AVTX) insider trading activity

Armistice Capital, LLC is > 10% Shareholder of Avalo Therapeutics, Inc.. Currently has a direct ownership of 39.1 Million shares of AVTX, which is worth approximately $380 Million. The most recent transaction as insider was on Aug 22, 2017, when has been sold 19,301 shares (Common Stock) at a price of $0.62 per share, resulting in proceeds of $11,967. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.1M

0% 3M change

0% 12M change

Total Value Held $380 Million

ARMISTICE CAPITAL, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 22 2017	BUY Open market or private purchase	$11,967 $0.62 p/Share	19,301 Added 0.12%	15,734,865 Common Stock
Aug 21 2017	BUY Open market or private purchase	$9,494 $0.61 p/Share	15,564 Added 0.1%	15,715,564 Common Stock
Aug 18 2017	BUY Open market or private purchase	$19,336 $0.61 p/Share	31,698 Added 0.2%	15,700,000 Common Stock
Aug 17 2017	BUY Open market or private purchase	$15,341 $0.59 p/Share	26,002 Added 0.17%	15,668,302 Common Stock

Also insider at

BBI

Brickell Biotech, Inc. Healthcare

> 10% Shareholder

ALIM

ALIMERA SCIENCES INC Healthcare

> 10% Shareholder

KPRX

KIORA PHARMACEUTICALS INC Healthcare

> 10% Shareholder

SAVA

CASSAVA SCIENCES INC Healthcare

> 10% Shareholder

DFRG

Del Frisco's Restaurant Group, Inc.

> 10% Shareholder

VLRX

Valeritas Holdings Inc.

> 10% Shareholder

BPTH

BIO-PATH HOLDINGS INC Healthcare

> 10% Shareholder

AYTU

AYTU BIOPHARMA, INC Healthcare

Director

ACHV

ACHIEVE LIFE SCIENCES, INC. Healthcare

> 10% Shareholder

AMAG

AMAG PHARMACEUTICALS, INC.

> 10% Shareholder

RSLS

ReShape Weightloss Inc.

> 10% Shareholder

INNV

INNOVUS PHARMACEUTICALS, INC.

> 10% Shareholder

ONTX

Onconova Therapeutics, Inc. Healthcare

> 10% Shareholder

VXRT

Vaxart, Inc. Healthcare

Director

TTPH

TETRAPHASE PHARMACEUTICALS INC

Director

TENX

TENAX THERAPEUTICS, INC. Healthcare

Director

CYTH

Cyclo Therapeutics, Inc. Healthcare

> 10% Shareholder

RSLS

ReShape Lifesciences Inc. Healthcare

> 10% Shareholder

ACL